Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis

  Free Subscription


15.01.2018

1 AIDS
2 Ann Intern Med
1 Arch Virol
1 BMC Gastroenterol
2 Hepatology
4 J Med Virol
6 J Viral Hepat
2 Lancet Gastroenterol Hepatol
2 PLoS One
1 Vaccine
2 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. MINGUEZ C, Garcia-Deltoro M, Flores J, Galindo MJ, et al
    Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients.
    AIDS. 2018;32:337-346.
    PubMed     Text format     Abstract available


    Ann Intern Med

  2. SCHVARTSMAN G, Perez K, Sood G, Katkhuda R, et al
    Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma.
    Ann Intern Med. 2017 Aug 1. doi: 10.7326/L17-0187.
    PubMed     Text format    

  3. JR AD
    Hearing From the Silent Epidemic.
    Ann Intern Med. 2017 May 9. doi: 10.7326/M17-0927.
    PubMed     Text format    


    Arch Virol

  4. BOGLIONE L, Cusato J, Pinna SM, De Nicolo A, et al
    Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.
    Arch Virol. 2018 Jan 9. pii: 10.1007/s00705-017-3684.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  5. CHEN CY, Tien FM, Cheng A, Huang SY, et al
    Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.
    BMC Gastroenterol. 2018;18:6.
    PubMed     Text format     Abstract available


    Hepatology

  6. CONGLY SE, Lee SS
    Treatment of Acute HCV Cost-Effective but at What Price?
    Hepatology. 2018 Jan 5. doi: 10.1002/hep.29771.
    PubMed     Text format    

  7. BETHEA E, Chen Q, Hur C, Chung RT, et al
    Response to Treatment of Acute HCV Cost-Effective but at What Price?
    Hepatology. 2018 Jan 5. doi: 10.1002/hep.29770.
    PubMed     Text format    


    J Med Virol

  8. GAMIL M, Alboraie M, El-Sayed M, Elsharkawy A, et al
    Novel scores combining AFP with non-invasive markers for prediction of liver fibrosis in chronic hepatitis C patients.
    J Med Virol. 2018 Jan 6. doi: 10.1002/jmv.25026.
    PubMed     Text format     Abstract available

  9. OHYA K, Akuta N, Suzuki F, Fujiyama S, et al
    Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2.
    J Med Virol. 2018 Jan 5. doi: 10.1002/jmv.25023.
    PubMed     Text format     Abstract available

  10. ALIDJINOU EK, Michel C, Canva V, Ajana F, et al
    Very slow decline of hepatitis B virus surface antigen and core related antigen in chronic hepatitis B patients successfully treated with nucleos(t)ide analogues.
    J Med Virol. 2018 Jan 9. doi: 10.1002/jmv.25028.
    PubMed     Text format     Abstract available

  11. MARIO S, Carmine M, Stefania P, Margherita M, et al
    VIROLOGICAL PATTERNS OF HCV PATIENTS WITH FAILURE TO INTERFERON-FREE REGIMENS.
    J Med Virol. 2018 Jan 9. doi: 10.1002/jmv.25022.
    PubMed     Text format     Abstract available


    J Viral Hepat

  12. SCHUTZ A, Moser S, Schwanke C, Schubert R, et al
    Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk for non-adherence to direct-acting antivirals.
    J Viral Hepat. 2018 Jan 5. doi: 10.1111/jvh.12857.
    PubMed     Text format     Abstract available

  13. FALADE-NWULIA O, Sulkowski MS, Merkow A, Latkin C, et al
    Understanding and addressing hepatitis C reinfection in the oral direct acting antiviral era.
    J Viral Hepat. 2018 Jan 6. doi: 10.1111/jvh.12859.
    PubMed     Text format     Abstract available

  14. YOUNG K, Haq K, MacLean S, Dudani R, et al
    Development of a recombinant murine tumor model using hepatoma cells expressing hepatitis C virus (HCV) non-structural antigens.
    J Viral Hepat. 2018 Jan 6. doi: 10.1111/jvh.12856.
    PubMed     Text format     Abstract available

  15. FLISIAK R, Zarebska-Michaluk D, Janczewska E, Staniaszek A, et al
    Treatment of HCV infection in Poland at the beginning of the interferon-free era - the EpiTer-2 study.
    J Viral Hepat. 2018 Jan 6. doi: 10.1111/jvh.12861.
    PubMed     Text format     Abstract available

  16. LAU KC, Osiowy C, Giles E, Lusina B, et al
    Deep Sequencing Shows Low Level Oncogenic Hepatitis B Virus Variants Persisting Post-Liver Transplant Despite Potent Anti-HBV Prophylaxis.
    J Viral Hepat. 2018 Jan 6. doi: 10.1111/jvh.12860.
    PubMed     Text format     Abstract available

  17. CHO H, Ahn H, Lee DH, Lee JH, et al
    Entecavir and Tenofovir Reduce Hepatitis B Virus-related Hepatocellular Carcinoma Recurrence More Effectively than Other Antivirals.
    J Viral Hepat. 2018 Jan 6. doi: 10.1111/jvh.12855.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  18. GREBELY J, Dalgard O, Conway B, Cunningham EB, et al
    Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
    Lancet Gastroenterol Hepatol. 2018 Jan 5. pii: S2468-1253(17)30404.
    PubMed     Text format     Abstract available

  19. ROSENTHAL ES, Kattakuzhy S, Kottilil S
    Time to end treatment restrictions for people with hepatitis C who inject drugs.
    Lancet Gastroenterol Hepatol. 2018 Jan 5. pii: S2468-1253(18)30001.
    PubMed     Text format    


    PLoS One

  20. CARIMO AA, Gudo ES, Maueia C, Mabunda N, et al
    First report of occult hepatitis B infection among ART naive HIV seropositive individuals in Maputo, Mozambique.
    PLoS One. 2018;13:e0190775.
    PubMed     Text format     Abstract available

  21. BIVIGOU-MBOUMBA B, Amougou-Atsama M, Zoa-Assoumou S, M'boyis Kamdem H, et al
    Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.
    PLoS One. 2018;13:e0190592.
    PubMed     Text format     Abstract available


    Vaccine

  22. RAMIREZ A, Morris S, Maucourant S, D'Ascanio I, et al
    A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31814.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  23. WEHMEYER MH, Hartl J, von Wulffen M, Lohse AW, et al
    Time trend of reported cases and publications: hepatitis E in comparison to hepatitis A - D in Germany from 2001 to 2016.
    Z Gastroenterol. 2018;56:29-35.
    PubMed     Text format     Abstract available

  24. WEILER-NORMANN C, Hartl J, Weidemann S, von Pein UM, et al
    Acute hepatitis as a prequel to very severe aplastic anemia.
    Z Gastroenterol. 2018;56:51-54.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: